Regenerative medication deals with the translational analysis in tissue engineering and biology that involves the method of exchange, tissues or organs to revive, engineering or create human cells. This field holds the promise of engineering broken tissues and organs by stimulating the bodys own repair mechanisms to functionally heal antecedently irreparable tissues or organs.
Regenerative medication conjointly includes the chance of growing tissues and organs within the laboratory and implanting them once the body cannot heal itself. If regenerated organs cells would be derived from the patients own tissue or cells, this could doubtless solve the matter of the shortage of organs obtainable for donation, and also the drawback of surgical procedure rejection.
Pharmacovigilance and Pharmacoepidemiology Journal is to publish high quality research in the discipline of Pharmacovigilance by providing encouragement for editors, reviewers, authors, and readers to have an uninterrupted scientific communication.